CGTX
USDCognition Therapeutics Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$0.315
Haut
$0.315
Bas
$0.306
Volume
0.54M
Fondamentaux de l'Entreprise
Capitalisation Boursière
19.7M
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
1.07M
Bourse
NCM
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
Philanthropic Donor Funds Cognition Therapeutics' Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies
Dr. James Galvin of the University of Miami to Serve as Lead Investigator First Site Initiated: Banner Sun Health Research Institute PURCHASE, N.Y., June 03, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc.,
Cognition Therapeutics Releases New Episode of "Conversations" Podcast: Studying the Patient/Caregiver Lived Experience in Dementia with Lewy Bodies
PURCHASE, N.Y., May 28, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the "Company" or "Cognition") (NASDAQ:CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, has released
HC Wainwright & Co. Maintains Buy on Cognition Therapeutics, Lowers Price Target to $3
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Cognition Therapeutics with a Buy and lowers the price target from $5 to $3.
Actions Connexes
PLMJU
Plum Acquisition Corp. III Unit
BIVI
BioVie Inc.
PAL
Proficient Auto Logistics Inc.
ONDS
Ondas Holdings Inc.
FITBO
Fifth Third Bancorp Depositary Shares each representing a 1/1000th ownership interest in a share of Non-Cumulative Perpetual Preferred Stock Series K
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.